Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Autogenous Vaccines Market: By Strain Type: Bacterial Strain, Virus Strain; By End Use: Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes, Others; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics; Value Chain Analysis; Competitive Landscape; Industry Events and Developments

Global Autogenous Vaccines Market Outlook

The global autogenous vaccines market is expected to grow at a CAGR of 4.3% in the forecast period of 2023-2028.

 

Autogenous Vaccines Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rising Provision of Funds by Several Governments is Aiding the Growth of Autogenous Vaccines Industry

The market for autogenous vaccines is driven by the rising provision of funds by several governments and international communities of public and private benefactors for the control and eradication programmes. For example, European Animal Health Strategy Programs have contributed significantly to the industry. The rising focus of government organisations towards the immunisation of animals is expected to propel the market growth over the forecast period. Further, the international agencies and organisations like Center for Disease Prevention and Control, Food and Agriculture Organization, and World Organization for Animal Health (OIE) have significantly contributed to the reduction of animal diseases and regulating and controlling programmes for animal diseases. Besides, the market is influenced by the growing focus on innovations for the prevention and treatment of zoonotic diseases.

 

Autogenous Vaccines Market by End Use

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Autogenous Vaccines: Market Segmentation

An autogenous vaccine is refers to a vaccine that is developed from cultures of microorganisms accumulated from individuals and then used to immunise the same individual against further propagation and development of the same microorganisms.

On the basis of strain type, the market is divided into:

  • Bacterial Strain
  • Virus Strain

Based on end use, the industry can be segmented into:

  • Veterinary Clinics
  • Veterinary Hospitals
  • Veterinary Research Institutes
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Autogenous Vaccines Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rising Prevalence of Contagious Diseases to Aid the Market Growth of Autogenous Vaccines Industry

The market for autogenous vaccines is driven by the rising prevalence of contagious diseases across the globe as it is generating demand for customised autogenous vaccines. Animals are susceptible to a wide range of contagious diseases like pink eyes and peste des petits ruminants (PPR) / goat plague, a highly contagious disease that generally affects ruminants. As reported by the Food and Agricultural Organization, peste des petits ruminants (PPR) virus or goat plague can contaminate approximately 90% of small ruminant inhabitants. The outbreak of contagious diseases severely interrupts livestock production, leading to direct and indirect financial losses. The government organisations as well as public organisations contribute the economic resources for the prevention and control of contagious infection in livestock, which is expected to facilitate the market growth of autogenous vaccines during the forecast period.

 

Key Industry Players in the Global Autogenous Vaccines Market

The report gives a detailed analysis of the following key players in the global autogenous vaccines market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Newport Laboratories, Inc.
  • Elanco Animal Health Inc.
  • Cambridge Technologies
  • Hygieia Biological Laboratories
  • AniCon Labor GmbH
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Strain Type, End Use, Region
Breakup by Strain Type Bacterial Strain, Virus Strain
Breakup by End Use Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes, Others
Breakup by Region North America, Latin America, Europe, Middle East and Africa, Asia Pacific
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Newport Laboratories, Inc., Elanco Animal Health Inc., Cambridge Technologies, Hygieia Biological Laboratories, AniCon Labor GmbH, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Autogenous Vaccines Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Autogenous Vaccines Historical Market (2018-2022) 
    8.3    Global Autogenous Vaccines Market Forecast (2023-2028)
    8.4    Global Autogenous Vaccines Market by Strain Type
        8.4.1    Bacterial Strain
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2022)
            8.4.1.3    Forecast Trend (2023-2028)
        8.4.2    Virus Strain
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2022)
            8.4.2.3    Forecast Trend (2023-2028)
    8.5    Global Autogenous Vaccines Market by End Use
        8.5.1    Veterinary Clinics
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2022)
            8.5.1.3    Forecast Trend (2023-2028)
        8.5.2    Veterinary Hospitals
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2022)
            8.5.2.3    Forecast Trend (2023-2028)
        8.5.3    Veterinary Research Institutes
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2018-2022)
            8.5.3.3    Forecast Trend (2023-2028)
        8.5.4    Others  8.6    Global Autogenous Vaccines Market by Region
        8.6.1    North America
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2018-2022)
            8.6.1.3    Forecast Trend (2023-2028)
        8.6.2    Europe
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2018-2022)
            8.6.2.3    Forecast Trend (2023-2028)
        8.6.3    Asia Pacific
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2018-2022)
            8.6.3.3    Forecast Trend (2023-2028)
        8.6.4    Latin America
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2018-2022)
            8.6.4.3    Forecast Trend (2023-2028)
        8.6.5    Middle East and Africa
            8.6.5.1    Market Share
            8.6.5.2    Historical Trend (2018-2022)
            8.6.5.3    Forecast Trend (2023-2028)
9    North America Autogenous Vaccines Market Analysis
    9.1    United States of America
        9.1.1    Market Share
        9.1.2    Historical Trend (2018-2022)
        9.1.3    Forecast Trend (2023-2028)
    9.2    Canada
        9.2.1    Market Share
        9.2.2    Historical Trend (2018-2022)
        9.2.3    Forecast Trend (2023-2028)
10    Europe Autogenous Vaccines Market Analysis
    10.1    United Kingdom
        10.1.1    Market Share
        10.1.2    Historical Trend (2018-2022)
        10.1.3    Forecast Trend (2023-2028)
    10.2    Germany
        10.2.1    Market Share
        10.2.2    Historical Trend (2018-2022)
        10.2.3    Forecast Trend (2023-2028)
    10.3    France
        10.3.1    Market Share
        10.3.2    Historical Trend (2018-2022)
        10.3.3    Forecast Trend (2023-2028)
    10.4    Italy
        10.4.1    Market Share
        10.4.2    Historical Trend (2018-2022)
        10.4.3    Forecast Trend (2023-2028)
    10.5    Others
11    Asia Pacific Autogenous Vaccines Market Analysis
    11.1    China
        11.1.1    Market Share
        11.1.2    Historical Trend (2018-2022)
        11.1.3    Forecast Trend (2023-2028)
    11.2    Japan
        11.2.1    Market Share
        11.2.2    Historical Trend (2018-2022)
        11.2.3    Forecast Trend (2023-2028)
    11.3    India
        11.3.1    Market Share
        11.3.2    Historical Trend (2018-2022)
        11.3.3    Forecast Trend (2023-2028)
    11.4    ASEAN
        11.4.1    Market Share
        11.4.2    Historical Trend (2018-2022)
        11.4.3    Forecast Trend (2023-2028)
    11.5    Australia
        11.5.1    Market Share
        11.5.2    Historical Trend (2018-2022)
        11.5.3    Forecast Trend (2023-2028)
    11.6    Others
12    Latin America Autogenous Vaccines Market Analysis
    12.1    Brazil
        12.1.1    Market Share
        12.1.2    Historical Trend (2018-2022)
        12.1.3    Forecast Trend (2023-2028)
    12.2    Argentina
        12.2.1    Market Share
        12.2.2    Historical Trend (2018-2022)
        12.2.3    Forecast Trend (2023-2028)
    12.3    Mexico
        12.3.1    Market Share
        12.3.2    Historical Trend (2018-2022)
        12.3.3    Forecast Trend (2023-2028)
    12.4    Others
13    Middle East and Africa Autogenous Vaccines Market Analysis
    13.1    Saudi Arabia
        13.1.1    Market Share
        13.1.2    Historical Trend (2018-2022)
        13.1.3    Forecast Trend (2023-2028)
    13.2    United Arab Emirates
        13.2.1    Market Share
        13.2.2    Historical Trend (2018-2022)
        13.2.3    Forecast Trend (2023-2028)
    13.3    Nigeria
        13.3.1    Market Share
        13.3.2    Historical Trend (2018-2022)
        13.3.3    Forecast Trend (2023-2028)
    13.4    South Africa
        13.4.1    Market Share
        13.4.2    Historical Trend (2018-2022)
        13.4.3    Forecast Trend (2023-2028)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Value Chain Analysis
16    Competitive Landscape

    16.1    Market Structure
    16.2    Company Profiles
        16.2.1    Newport Laboratories, Inc.
            16.2.1.1    Company Overview
            16.2.1.2    Product Portfolio
            16.2.1.3    Demographic Reach and Achievements
            16.2.1.4    Certifications
        16.2.2    Elanco Animal Health Inc.
            16.2.2.1    Company Overview
            16.2.2.2    Product Portfolio
            16.2.2.3    Demographic Reach and Achievements
            16.2.2.4    Certifications
        16.2.3    Cambridge Technologies
            16.2.3.1    Company Overview
            16.2.3.2    Product Portfolio
            16.2.3.3    Demographic Reach and Achievements
            16.2.3.4    Certifications
        16.2.4    Hygieia Biological Laboratories
            16.2.4.1    Company Overview
            16.2.4.2    Product Portfolio
            16.2.4.3    Demographic Reach and Achievements
            16.2.4.4    Certifications
        16.2.5    AniCon Labor GmbH
            16.2.5.1    Company Overview
            16.2.5.2    Product Portfolio
            16.2.5.3    Demographic Reach and Achievements
            16.2.5.4    Certifications
        16.2.6    Others
17    Key Trends and Developments in the Market

 

List of Key Figures and Tables

1.    Global Autogenous Vaccines Market: Key Industry Highlights, 2018 and 2028
2.    Global Autogenous Vaccines Historical Market: Breakup by Strain Type (USD Billion), 2018-2022
3.    Global Autogenous Vaccines Market Forecast: Breakup by Strain Type (USD Billion), 2023-2028
4.    Global Autogenous Vaccines Historical Market: Breakup by End Use (USD Billion), 2018-2022
5.    Global Autogenous Vaccines Market Forecast: Breakup by End Use (USD Billion), 2023-2028
6.    Global Autogenous Vaccines Historical Market: Breakup by Region (USD Billion), 2018-2022
7.    Global Autogenous Vaccines Market Forecast: Breakup by Region (USD Billion), 2023-2028
8.    North America Autogenous Vaccines Historical Market: Breakup by Country (USD Billion), 2018-2022
9.    North America Autogenous Vaccines Market Forecast: Breakup by Country (USD Billion), 2023-2028
10.    Europe Autogenous Vaccines Historical Market: Breakup by Country (USD Billion), 2018-2022
11.    Europe Autogenous Vaccines Market Forecast: Breakup by Country (USD Billion), 2023-2028
12.    Asia Pacific Autogenous Vaccines Historical Market: Breakup by Country (USD Billion), 2018-2022
13.    Asia Pacific Autogenous Vaccines Market Forecast: Breakup by Country (USD Billion), 2023-2028
14.    Latin America Autogenous Vaccines Historical Market: Breakup by Country (USD Billion), 2018-2022
15.    Latin America Autogenous Vaccines Market Forecast: Breakup by Country (USD Billion), 2023-2028
16.    Middle East and Africa Autogenous Vaccines Historical Market: Breakup by Country (USD Billion), 2018-2022
17.    Middle East and Africa Autogenous Vaccines Market Forecast: Breakup by Country (USD Billion), 2023-2028
18.    Global Autogenous Vaccines Market Structure

Key Questions Answered in the Report

The global autogenous vaccines market is projected to grow at a CAGR of 4.3% between 2021 and 2026.

The major drivers of the industry, such as rising disposable incomes, increasing population, rising prevalence of contagious diseases, changing lifestyles, and growing government funding, are expected to aid the market growth.

The key market trend guiding the growth of the market includes the growing focus on innovations for the prevention and treatment of zoonotic diseases.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The leading strain types in the market are bacterial strain and virus strain.

The major end use sectors in the market are veterinary clinics, veterinary hospitals, and veterinary research institutes, among others.

The major players in the industry are Newport Laboratories, Inc., Elanco Animal Health Inc., Cambridge Technologies, Hygieia Biological Laboratories, and AniCon Labor GmbH, among others.

Analyst Review

The global autogenous vaccines market is being driven by the growing prevalence of contagious diseases. Aided by the rising innovations, the market is expected to witness a moderate growth in the forecast period of 2023-2028, growing at a CAGR of 4.3%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on strain type, the market is segmented into bacterial strain and virus strain. By end use, the industry is divided into veterinary clinics, veterinary hospitals, and veterinary research institutes, among others. The major regional markets for autogenous vaccines are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Newport Laboratories, Inc., Elanco Animal Health Inc., Cambridge Technologies, Hygieia Biological Laboratories, and AniCon Labor GmbH, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER